Global Alopecia Market Overview
Hair loss and damage, commonly known as alopecia, is becoming common as a result of a sedentary lifestyle, poor dietary habits, and rising stress levels. Alopecia is caused by several reasons, including aging, hormone imbalances, and the rising frequency of cancer, arthritis, hypertension, and depression. Alopecia Universalis is the least common autoimmune condition, with less than 5% of the population suffering from alopecia. Extensive alopecia can be difficult to treat, and individuals may not respond to treatment. Anti-inflammatory medicines, such as topical and intralesional corticosteroid injections, are the most commonly given treatments for hair growth. 
To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2015 to forecast the market through 2027. 2019 is considered a base year however 2020’s numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.
Global Alopecia Market Dynamics
Gradual changes in eating habits, excessive intake of poor food, adoption of a sedentary lifestyle, related stress and aging, hormonal imbalance, high incidence of hereditary and chronic illnesses are significant factors leading to hair fall and baldness. Moreover, the growing incidence of chronic illnesses like Polycystic Ovary Disease, hyperthyroidism, acute stress disorder, hypothyroidism, cancer, lupus, hypopituitarism, and high consumption of cigarettes and alcohol are fueling the global market growth. The availability of low laser therapy, which helps encourage hair growth, is likely to boost the number of people treated for hair loss. Recent product development, such as the FDA-approved introduction of rapidly acting JAK drugs, the development of methods to stimulate hair growth using human pluripotent stem cells, and the development of PRP treatment, that specifically stimulates hair growth in men, are all driving factors. hairmax laser comb, follinex massager comb, lifemax infrared hairbrush, and hair growth renewing lasers are examples of technologically advanced products built on modern technologies. These are some of the most important factors expected to drive the growth of the market. 
Restraints: Fears about Finasteride’s potential adverse effects, such as skin rash, ejaculation dysfunction, and the danger of prostate cancer, operate as limiting factors. High treatment costs and the risk of infection on the scalp following hair transplant surgery are also likely to deter patients from seeking therapy, which are the other factors expected to hamper the market’s growth.
Global Alopecia Market Segmentation Analysis
By End-use, the dermatology segment dominated the market, accounting for 57.6 percent of total revenue. The segment’s ongoing growth is attributed to modern treatment methods like laser technology, a robust product pipeline, and increased consumer knowledge about the usage of prescription medications. The ability of a consulting dermatologist to give appropriate tailored drugs or treatments that provide successful outcomes makes them a popular choice for alopecia treatment. By Gender, Due to the high prevalence of hair loss in the male world population, the male alopecia segment accounted for the largest revenue share of 53.8 percent in 2019. Androgenetic alopecia is the most common kind of alopecia in males. At the age of 50, it is expected that half of all males had some form of hair loss. Furthermore, the market is expected to be driven by factors such as an aging population and increased tobacco consumption among men over the forecast period. Female alopecia is expected to grow at the highest pace over the forecast period. The growing awareness is attributed to the high prevalence of Polycystic Ovary Syndrome (PCOS), which causes a hormonal imbalance that leads to androgenetic alopecia.
Global Alopecia Market Regional Insights
North America dominated the market in 2019, accounting for 36.3 percent of total sales. High disease prevalence, rising consumer awareness, proactive government measures, technological advancements, and improvements in healthcare infrastructure are all driving the market forward. The presence of major companies in this region is a major driving force for future growth. Furthermore, increasing the use of laser-based therapy to treat alopecia is improving the region’s treatment rate. 
The Asia Pacific market is expected to grow at the fastest CAGR throughout the forecast period, owing to increased alopecia product penetration, growing disposable income, and rising consumer awareness. Furthermore, strengthening the healthcare regulatory environment in developing countries is likely to attract foreign firms looking to invest and capitalize on existing market possibilities.
Global Alopecia Market Scope: Inquire before buying
Global Alopecia Market by Region
• North America • Asia pacific • Europe • Middle East and Africa • South America
Global Alopecia Market: Key Players
• iGrow Laser (Apira Science, Inc) • Theradome • Curallux, LLC (Capillus) • LUTRONIC • iRestore Hair Growth System (Freedom Laser Therapy) • Lexington Intl., LLC. (HairMax) • Vitabiotics • Sun Pharma • Merck & Co. • Alpecin • Dr. Reddy’s Laboratories • Cipla • Johnson & Johnson • Kirkland Signature • Phyto Ales Group • Lifes2good
Frequently Asked Questions
1. What is the projected market size & growth rate of the Global Alopecia Market? Ans- Alopecia Market was valued at USD 7.7 billion in 2019 and is projected to reach USD 12.36 billion by 2027, growing at a CAGR of 8.2% during the forecast period. 2. What are the key driving factors for the growth of the Global Alopecia Market? Ans- the growing incidence of chronic illnesses like Polycystic Ovary Disease, hyperthyroidism, acute stress disorder, hypothyroidism, cancer, lupus, hypopituitarism, and high consumption of cigarettes and alcohol are fueling the global market growth. 3. Which region accounted for the largest Global Alopecia Market share? Ans- North America dominated the market in 2019, accounting for 36.3 percent of total sales. 4. What makes the Asia Pacific a Lucrative Market for Global Alopecia Market? Ans- Strengthening the healthcare regulatory environment in developing countries is likely to attract foreign firms looking to invest and capitalize on existing market possibilities. 5. What are the top players operating in the Global Alopecia Market? Ans- iRestore Hair Growth System (Freedom Laser Therapy), iGrow Laser (Apira Science, Inc), Theradome, Curallux, LLC (Capillus), LUTRONIC, Lexington Intl., LLC. (HairMax), Vitabiotics, and Sun Pharma.
